Rgenix
New York, US
Biotech
Founders & leadership
DD
David DarstChief Operating Officer
SS
Shahram Seyedin-NoorExecutive Chairman
NC
Nancy ChangDirector
IK
Isabel KurthVice President - Research
MT
Masoud TavazoieChief Scientific Officer
Reported raises · per SEC filings
Form D private placements$55.1MraisedAug 2022 · 20 investors · Biotechnology
Rule 506(b)$6MraisedFeb 2021 · 10 investors · Biotechnology
Rule 506(b)$39.8MraisedOct 2018 · 10 investors · Biotechnology
Rule 506(b)$33MraisedJun 2016 · 8 investors · Biotechnology
Rule 506(b)$8MraisedAug 2015 · 33 investors · Biotechnology
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.